Syndax Pharmaceuticals Stock Price - SNDX

15.75
0.06 (0.38%)
15.69
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Syndax Pharmaceuticals Inc SNDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.31 -1.94% 15.69 15.65 17.75 16.61 16.00 17:39:05
Bid Price Ask Price Spread Spread % News
15.70 16.00 0.30 1.88% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
10,993 1,036,421 $ 16.64 $ 17,242,616 1,401,290 5.35 - 21.97
Last Trade Time Type Quantity Stock Price Currency
17:31:56 15 $ 15.75 USD

Syndax Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 566.33M 36.09M 36.02M $ 1.52M $ - -1.85 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 15.00 0.30%

more financials information »

Syndax Pharmaceuticals News

Date Time Source News Article
5/21/202016:35PR Newswire (US)ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of..
5/12/202016:05PR Newswire (US)Syndax Announces Closing of Public Offering of Common Stock..
5/11/202017:18Edgar (US Regulatory)Statement of Ownership (sc 13g)
5/07/202016:55Edgar (US Regulatory)Quarterly Report (10-q)
5/07/202016:13Edgar (US Regulatory)Current Report Filing (8-k)
5/07/202016:05PR Newswire (US)Syndax Pharmaceuticals Reports First Quarter 2020 Financial..
5/04/202008:50Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SNDX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week20.8121.9715.2516.972,384,467-5.12-24.6%
1 Month14.2521.9713.0018.642,042,5181.4410.11%
3 Months9.7121.976.8816.96802,4215.9861.59%
6 Months7.2421.976.3215.36476,9028.45116.71%
1 Year7.5621.975.3513.69307,5498.13107.54%
3 Years12.9221.973.3910.54270,2352.7721.44%
5 Years12.1121.973.3910.79224,1983.5829.56%

Syndax Pharmaceuticals Description

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidate are entinostat which has direct effects on both cancer cells and immune regulatory cells, and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
Your Recent History
NASDAQ
SNDX
Syndax Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200526 22:02:37